OptiBiotix Health plc
OPTBF
$0.11
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 372.00K | 350.80K | 380.40K | 386.50K | 174.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 372.00K | 350.80K | 380.40K | 386.50K | 174.10K |
| Cost of Revenue | 169.70K | 160.00K | 239.50K | 243.30K | 104.10K |
| Gross Profit | 202.40K | 190.80K | 140.90K | 143.10K | 70.00K |
| SG&A Expenses | 1.09M | 1.03M | 788.90K | 801.60K | 675.50K |
| Depreciation & Amortization | 68.10K | 64.20K | -67.90K | -69.00K | 66.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.33M | 1.26M | 1.15M | 1.17M | 846.50K |
| Operating Income | -959.80K | -904.90K | -768.40K | -780.80K | -672.40K |
| Income Before Tax | -790.10K | -745.00K | 597.40K | 607.10K | -1.77M |
| Income Tax Expenses | -4.00K | -3.80K | -33.90K | -34.50K | -5.00K |
| Earnings from Continuing Operations | -786.10K | -741.20K | 631.40K | 641.50K | -1.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -786.10K | -741.20K | 631.40K | 641.50K | -1.76M |
| EBIT | -959.80K | -904.90K | -768.40K | -780.80K | -672.40K |
| EBITDA | -891.70K | -840.70K | -702.40K | -713.80K | -605.50K |
| EPS Basic | -0.01 | -0.01 | 0.01 | 0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | 0.01 | 0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 102.38M | 102.38M | 101.35M | 101.35M | 94.46M |
| Average Diluted Shares Outstanding | 102.38M | 102.38M | 101.35M | 101.35M | 94.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |